Vivanza Biosciences Ltd
Board Meeting Intimation for Consideration Of Financial Result For The Quarter And Nine Months Ended 31St December 2025
03:45 PM, 5th Feb 2026
Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Pursuant to Regulations 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday February 12 2026 at the Registered Office of the Company inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter and nine months ended December 31 2025 and any other business with the permission of the Chair.In terms of Regulation 46 of the SEBI LODR Regulations the intimation shall be available on the Companys website at https://vivanzabiosciences.com/announcement/.Further pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct the trading window has been closed and shall remain closed till 48 hours after the declaration of the aforesaid financial results.